Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous
Pharma
Halozyme wins Keytruda SC injunction in several European markets
After facing a setback in Germany last year, Merck & Co.’s European marketing plans for its below-the-skin Keytruda SC are growing more complicated.
Fraiser Kansteiner
Oct 7, 2026 11:08am
Biogen taps Alteogen for help developing 2 subQ biologics
Mar 25, 2026 10:55am
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli
Jan 20, 2026 2:26pm
Roche's bispecific Lunsumio goes subcutaneous
Dec 22, 2025 10:15am
Argenx cans Vyvgart trials in thyroid eye disease over futility
Dec 15, 2025 10:00am
Halozyme CEO targets new deals as IRA uncertainty subsides
Oct 14, 2025 9:40am
